Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Journal of Cellular Physiology|October 30, 2003
Overexpression of thioredoxin reductase 1 regulates NF-kappa B activationAtsuko Sakurai, Kouji Yuasa, Yasuko Shoji, et al.Journal of Diabetes Investigation|May 9, 2022
Comparison of the clinical effects of intermittently scanned and real-time continuous glucose monitoring in children and adolescents with type 1 diabetes: A retrospective cohort studyTatsuhiko Urakami, Hiroki Terada, Kei Yoshida, et al.Vaccine|June 9, 2024
Efficacy and safety of bivalent RSVpreF maternal vaccination to prevent RSV illness in Japanese infants: Subset analysis from the pivotal randomized phase 3 MATISSE trialTakeo Otsuki, Shinobu Akada, Ai Anami, et al.Human Vaccines & Immunotherapeutics|March 16, 2018
Late onset of injection site reactions after vaccination with the 13-valent pneumococcal conjugate vaccine in adult study populationsChristine Juergens, James Trammel, Yasuko Shoji, et al.Human Genome Variation|March 21, 2020
MIRAGE syndrome caused by a novel missense variant (p.Ala1479Ser) in the <i>SAMD9</i> geneShinsuke Onuma, Tamaki Wada, Ryosuke Araki, et al.Human Vaccines & Immunotherapeutics|July 16, 2015
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to the 23-valent pneumococcal polysaccharide vaccine in elderly Japanese adultsMasanari Shiramoto, Ryuzo Hanada, Christine Juergens, et al.Clinical Pediatric Endocrinology : Case Reports and Clinical Investigations : Official Journal of the Japanese Society for Pediatric Endocrinology|April 4, 2024
Genetic backgrounds and genotype-phenotype relationships in anthropometric parameters of 116 Japanese individuals with Noonan syndromeYasuko Shoji, Ayaha Hata, Takatoshi Maeyama, et al.Human Vaccines & Immunotherapeutics|August 8, 2018
Safety, tolerability, and immunogenicity of a novel 4-antigen <i>Staphylococcus aureus</i> vaccine (SA4Ag) in healthy Japanese adultsMegumi Inoue, Takuma Yonemura, James Baber, et al.Vaccine|September 26, 2021
A phase 3, multicenter, single-arm, open-label study to assess the safety, tolerability, and immunogenicity of a single dose of 13-valent pneumococcal conjugate vaccine in Japanese participants aged 6-64 years who are considered to be at increased risk of pneumococcal disease and who are naive to pneumococcal vaccinesYoshitaka Yamazaki, Masanori Ikeda, Takayuki Imada, et al.Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|November 4, 2016
Ovarian insufficiency following allogeneic hematopoietic stem cell transplantationMahiru Kawano, Hiroko Komura, Haruna Kawaguchi, et al.Pageof 3